Nnabuike C Ngene1, Jagidesa Moodley2. 1. Department of Obstetrics and Gynaecology, University of KwaZulu-Natal, South Africa. Electronic address: ngenenc@gmail.com. 2. Women's Health and HIV Research Group, Department of Obstetrics and Gynaecology, University of KwaZulu-Natal, South Africa.
Abstract
OBJECTIVE: The baseline blood pressure (BP) readings of an automated device that have not been validated in pregnancy require comparison with those from a reference standard before the device is utilized in pregnancy. We aimed to perform a baseline check of BP readings of an automated device, Mindray iMEC12 patient monitor, in severe pre-eclampsia and healthy pregnancy. STUDY DESIGN: The BP of 50 severe pre-eclamptic and 90 normotensive pregnancies were measured using Mindray iMEC12 patient monitor (test device) and Welch Allyn 767 aneroid sphygmomanometer (reference device). A pass in either the International Organization for Standardization (ISO) or British Hypertension Society (BHS) rating was considered acceptable. The cumulative percentage of absolute BP difference between the test and reference devices within 5, 10 and 15 mmHg were calculated to rate the test device according to the BHS grades (A, B, C or D). The ISO recommends that an accurate device should achieve a mean BP difference ± SD of ≤5 ± 8 mmHg. RESULTS: The mean BP difference between the test and reference devices were 1.27 ± 7.51 mmHg and 0.05 ± 6.09 mmHg for systolic and diastolic BPs respectively. The test device achieved the BHS grades B and A rating in systolic and diastolic BPs respectively. In each of the 2 groups (pre-eclamptic and normotensive pregnancies), the test device also satisfied the set pass criteria. CONCLUSIONS: In settings that do not have a validated BP device, Mindray iMEC12 patient monitor may be used for BP measurement in normotensive and severe pre-eclamptic pregnancies.
OBJECTIVE: The baseline blood pressure (BP) readings of an automated device that have not been validated in pregnancy require comparison with those from a reference standard before the device is utilized in pregnancy. We aimed to perform a baseline check of BP readings of an automated device, Mindray iMEC12 patient monitor, in severe pre-eclampsia and healthy pregnancy. STUDY DESIGN: The BP of 50 severe pre-eclamptic and 90 normotensive pregnancies were measured using Mindray iMEC12 patient monitor (test device) and Welch Allyn 767 aneroid sphygmomanometer (reference device). A pass in either the International Organization for Standardization (ISO) or British Hypertension Society (BHS) rating was considered acceptable. The cumulative percentage of absolute BP difference between the test and reference devices within 5, 10 and 15 mmHg were calculated to rate the test device according to the BHS grades (A, B, C or D). The ISO recommends that an accurate device should achieve a mean BP difference ± SD of ≤5 ± 8 mmHg. RESULTS: The mean BP difference between the test and reference devices were 1.27 ± 7.51 mmHg and 0.05 ± 6.09 mmHg for systolic and diastolic BPs respectively. The test device achieved the BHS grades B and A rating in systolic and diastolic BPs respectively. In each of the 2 groups (pre-eclamptic and normotensive pregnancies), the test device also satisfied the set pass criteria. CONCLUSIONS: In settings that do not have a validated BP device, Mindray iMEC12 patient monitor may be used for BP measurement in normotensive and severe pre-eclamptic pregnancies.
Authors: Eoin O'Brien; Thomas Pickering; Roland Asmar; Martin Myers; Gianfranco Parati; Jan Staessen; Thomas Mengden; Yutaka Imai; Bernard Waeber; Paolo Palatini; William Gerin Journal: Blood Press Monit Date: 2002-02 Impact factor: 1.444
Authors: Laura A Magee; Anouk Pels; Michael Helewa; Evelyne Rey; Peter von Dadelszen Journal: Pregnancy Hypertens Date: 2014-02-25 Impact factor: 2.899
Authors: Yong Ma; Marinella Temprosa; Sarah Fowler; Ronald J Prineas; Maria G Montez; Janet Brown-Friday; Mary L Carrion-Petersen; Tracy Whittington Journal: Am J Hypertens Date: 2008-12-04 Impact factor: 2.689
Authors: Hannah L Nathan; Annemarie de Greeff; Natasha L Hezelgrave; Lucy C Chappell; Andrew H Shennan Journal: Blood Press Monit Date: 2015-02 Impact factor: 1.444
Authors: James E Sharman; Alberto P Avolio; Johannes Baulmann; Athanase Benetos; Jacques Blacher; C Leigh Blizzard; Pierre Boutouyrie; Chen-Huan Chen; Phil Chowienczyk; John R Cockcroft; J Kennedy Cruickshank; Isabel Ferreira; Lorenzo Ghiadoni; Alun Hughes; Piotr Jankowski; Stephane Laurent; Barry J McDonnell; Carmel McEniery; Sandrine C Millasseau; Theodoros G Papaioannou; Gianfranco Parati; Jeong Bae Park; Athanase D Protogerou; Mary J Roman; Giuseppe Schillaci; Patrick Segers; George S Stergiou; Hirofumi Tomiyama; Raymond R Townsend; Luc M Van Bortel; Jiguang Wang; Siegfried Wassertheurer; Thomas Weber; Ian B Wilkinson; Charalambos Vlachopoulos Journal: Eur Heart J Date: 2017-10-01 Impact factor: 29.983